Related articles

• Randomized Controlled Trial

  Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial.

  Lancet Oncol. 2014 Jul 1; 15 (8): 799808799-808.

• Randomized Controlled Trial

  Randomized, double-blind, placebo-controlled phase II study of AMG 386 combined with weekly paclitaxel in patients with recurrent ovarian cancer.

  J. Clin. Oncol. 2012 Feb 1;30(4):362-71.

• Randomized Controlled Trial

  Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 2 trial.

  Lancet Oncol. 2012 Sep 1; 13 (9): 897-905.

Show more related articles...